ES2033922T3 - Procedimiento para preparar nuevos derivados de xantina. - Google Patents

Procedimiento para preparar nuevos derivados de xantina.

Info

Publication number
ES2033922T3
ES2033922T3 ES198787810481T ES87810481T ES2033922T3 ES 2033922 T3 ES2033922 T3 ES 2033922T3 ES 198787810481 T ES198787810481 T ES 198787810481T ES 87810481 T ES87810481 T ES 87810481T ES 2033922 T3 ES2033922 T3 ES 2033922T3
Authority
ES
Spain
Prior art keywords
hydroxy
metoxy
methyl
xantina
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787810481T
Other languages
English (en)
Inventor
Zoltan L. Kis
John Morley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Sandoz AG
Original Assignee
Sandoz Erfindungen Verwaltungs GmbH
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620825A external-priority patent/GB8620825D0/en
Priority claimed from GB878702129A external-priority patent/GB8702129D0/en
Priority claimed from GB878703435A external-priority patent/GB8703435D0/en
Application filed by Sandoz Erfindungen Verwaltungs GmbH, Sandoz AG filed Critical Sandoz Erfindungen Verwaltungs GmbH
Application granted granted Critical
Publication of ES2033922T3 publication Critical patent/ES2033922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN COMPUESTO DE FORMULA (I) EN DONDE R1 ES C ALQUIL, C3-4 ALQUENIL O (C3-5 CICLOALQUIL)-METIL, R2 ES C1-4 ALQUIL [HIDROXI- O (C1-4 ALCOXI)-SUSTITUIDO C1-3ALQUIL]-METIL, (C3,5 CICLOALQUIL)-METIL, TETRAHIDROFURANO-2-IL-METIL) O 1,3 DIOXOLANO-2-IL-METIL, R3 Y R4 SON CADA UNO HIDROGENO, HIDROXIMETIL, METOXIMETIL O N,N-DIMETILCARBAMOILOXIMETIL, R5 ES HIDROXI O METOXI, R6 ES HIDROGENO, HIDROXI, METOXI O HALOGENO, Y R7 ESTA EN LA POSICION 2- O 3- Y ES HIDROXI, METOXI O HALOGENO, O JUNTO CON R5 ES 3,4 METILENDIOXI O JUNTO CON R6 ES 2,3 METILENDIOXI Y SUS ESTERES HIDROLIZABLES FISIOLOGICAMENTE ACEPTABLES, SON UTILES PARA EL TRATAMIENTO (SINTOMATICO Y PROFILACTICO), DE LAS ENFERMEDADES DE OBSTRUCION O INFLAMACION DE LAS VIAS RESPIRATORIAS, EN PARTICULAR ASMA, Y ENFERMEDADES CARACTERIZADAS POR TENER UNA ETIOLOGIA QUE COMPRENDE ACUMULACION O ACTIVACION MORBIDA DE EOSINOFILIA, COMO POR EJEMPLO LA HIPEREOSINOFILIA.
ES198787810481T 1986-08-28 1987-08-25 Procedimiento para preparar nuevos derivados de xantina. Expired - Lifetime ES2033922T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868620825A GB8620825D0 (en) 1986-08-28 1986-08-28 Organic compounds
GB878702129A GB8702129D0 (en) 1987-01-30 1987-01-30 Organic compounds
GB878703435A GB8703435D0 (en) 1987-02-13 1987-02-13 Organic compounds

Publications (1)

Publication Number Publication Date
ES2033922T3 true ES2033922T3 (es) 1993-04-01

Family

ID=27263135

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787810481T Expired - Lifetime ES2033922T3 (es) 1986-08-28 1987-08-25 Procedimiento para preparar nuevos derivados de xantina.

Country Status (17)

Country Link
EP (1) EP0258191B1 (es)
JP (1) JPH0631236B2 (es)
KR (1) KR880002870A (es)
AU (1) AU600021B2 (es)
CA (1) CA1289954C (es)
DE (1) DE3779374D1 (es)
DK (1) DK169337B1 (es)
ES (1) ES2033922T3 (es)
FI (1) FI87356C (es)
GR (1) GR3004747T3 (es)
HU (1) HU199840B (es)
IE (1) IE60512B1 (es)
IL (1) IL83659A (es)
MY (1) MY101830A (es)
NZ (1) NZ221571A (es)
PH (1) PH24761A (es)
PT (1) PT85594B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
EP0799040B1 (en) 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
CA2206287C (en) * 1994-12-13 2001-03-20 Mark Chasin Aryl thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
DE60226615D1 (es) 2001-08-28 2008-06-26 Schering Corp
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1024968B (de) * 1956-03-31 1958-02-27 Asal Fabrik Biolog Und Pharmaz Verfahren zur Herstellung von 7-Ketonyl-8-amino-theophyllinen
AT212847B (de) * 1959-08-13 1961-01-10 Hans Dr Med Voigt Verfahren zur Herstellung des neuen Coffeino-(8)-(β-Phenyl-isopropyl)-amin
FR2157727A1 (en) * 1971-10-29 1973-06-08 Brun Lab Sa Le !,#dimethyl-8-aminopurines - with analgesicantitussive and other theophylline-like activities
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
DE3400951A1 (de) * 1984-01-13 1985-07-18 Robert Bosch Gmbh, 7000 Stuttgart Verfahren und vorrichtung zur drehzahlregelung bei einer brennkraftmaschine
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL83659A (en) 1991-06-10
EP0258191B1 (en) 1992-05-27
HUT47111A (en) 1989-01-30
IE60512B1 (en) 1994-07-27
DK448787A (da) 1988-02-29
DK448787D0 (da) 1987-08-27
FI87356C (fi) 1992-12-28
DK169337B1 (da) 1994-10-10
NZ221571A (en) 1990-11-27
FI87356B (fi) 1992-09-15
PT85594A (en) 1987-09-01
HU199840B (en) 1990-03-28
AU7744587A (en) 1988-03-03
PT85594B (pt) 1990-05-31
PH24761A (en) 1990-10-01
FI873704A (fi) 1988-02-29
IL83659A0 (en) 1988-01-31
JPS6363679A (ja) 1988-03-22
GR3004747T3 (es) 1993-04-28
KR880002870A (ko) 1988-05-12
DE3779374D1 (en) 1992-07-02
CA1289954C (en) 1991-10-01
AU600021B2 (en) 1990-08-02
JPH0631236B2 (ja) 1994-04-27
IE872296L (en) 1988-02-28
MY101830A (en) 1992-01-31
EP0258191A1 (en) 1988-03-02
FI873704A0 (fi) 1987-08-26

Similar Documents

Publication Publication Date Title
ES2033922T3 (es) Procedimiento para preparar nuevos derivados de xantina.
ES2052550T3 (es) 9-alfa-hidroxiesteroides, procedimiento para su preparacion y procedimiento para la preparacion de los correspondientes derivados 9(11)-deshidro.
EP0235642A3 (en) Arrangement for the aeration of compressor rotor parts of gas turbine power units
SE0000305L (sv) Förfarande och anordning vid superstruktur till implantat
NO931852L (no) Geldannende, flytende baerermateriale
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
DE3860911D1 (de) Keramische rotoren fuer druckwellenturbolader und deren herstellung.
FI871750A (fi) Nasal administration av laekemedel.
NZ191676A (en) Dental handpiece turbine bearing mounts
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
FI871345A0 (fi) Zwitterjoniska, bicykliska foereningar och deras salter, solvater, hydrater och estrar.
ATE26605T1 (de) Keramischer rotor.
AR004480A1 (es) Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
NO984131L (no) Kunstig mineralullblanding
ES2095068T3 (es) Peroxicarbonatos polimericos y procedimiento para prepararlos.
PT83478B (pt) Processo para a prepracao de novos derivados polioxigenados de labdano e de composicoes farmaceuticas que os contem
ES2062805T3 (es) Procedimiento para la preparacion de sulfatos ciclicos.
IT1193595B (it) Prgano di comando,in particolare per la messa in marcia di turbine di servizio a aria per velivoli
ATE81980T1 (de) Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DK282187A (da) Forstoever med tilfoersel af hjaelpeluft
ES2062455T3 (es) Nuevos derivados de benzonaftiridina-1,8, su preparacion y las composiciones que les contienen.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 258191

Country of ref document: ES